Tevogen Inc. — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Tevogen Inc. has established a 2024 Omnibus Incentive Plan under which it grants restricted stock awards to employees. The awards vest only upon achievement of a $1 billion aggregate revenue threshold by September 30, 2031. The filing does not disclose the specific number of shares granted, grantee names, or grant dates—it presents only the form template and terms. Key provisions include automatic forfeiture if revenue target is missed, clawback rights for misconduct or competing activities within 12 months post-termination, and transfer restrictions until vesting.
Why this rating
This is a standard equity plan adoption and form filing. No specific awards, amounts, or grantees are quantified. Relative to the $63.7M market cap, the document discloses terms but no material dollar exposure. Routine governance matter.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.